<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27574642</article-id><article-id pub-id-type="pmc">4994507</article-id><article-id pub-id-type="publisher-id">20010018</article-id><article-id pub-id-type="doi">10.4103/2321-3868.126086</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Role of CD8<sup>+</sup> regulatory T cells in organ transplantation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Su</surname><given-names>Jiyan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Qingfeng</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Xu</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Xian C.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Dai</surname><given-names>Zhenhua</given-names></name><address><email>zdai2009@outlook.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>Immunobiology and Transplantation Research Center, Houston, Methodist Research Institute, Houston, Texas USA </aff><aff id="Aff2"><label>2</label>Center for Regenerative and Translational Medicine, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine and Guangzhou University of Chinese Medicine School of Chinese Material Medica, Guangzhou, Guangdong, China </aff><aff id="Aff3"><label>3</label>Center for Regenerative and Translational Medicine, Guangdong Provincial Academy of Chinese Medical Sciences and the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, 55 Nei Huan Xi Lu, College Town, Guangzhou, Guangdong, 510006 P.R. China </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>1</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>1</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>2</volume><issue>1</issue><fpage>18</fpage><lpage>23</lpage><permissions><copyright-statement>&#x000a9; Author 2014</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made</license-p></license></permissions><abstract id="Abs1"><p>CD8<sup>+</sup> T cells are regulatory T cells (Tregs) that suppress both alloimmunity and autoimmunity in many animal models. This class of regulatory cells includes the CD8<sup>+</sup>CD28<sup>&#x02212;</sup>, CD8<sup>+</sup>CD103<sup>+</sup>, CD8<sup>+</sup>FoxP3<sup>+</sup> and CD8<sup>+</sup>CD122<sup>+</sup> subsets. The mechanisms of action of these regulatory cells are not fully understood; however, the secretion of immunosuppressive cytokines, such as interleukin (IL)-4, IL-10 and transforming growth factor beta (TGF-&#x003b2;) as well as the direct killing of target cells via Fas L/Fas and the perforin/granzyme B pathways have been demonstrated in various models. Further studies are necessary to fully understand the mechanisms underlying the suppressive effects of Tregs and to provide experimental support for potential clinical trials. We recently observed that CD8<sup>+</sup>CD122<sup>+</sup> Tregs more potently suppressed allograft rejection compared to their CD4<sup>+</sup>CD25<sup>+</sup> counterparts, supporting the hypothesis that CD8<sup>+</sup> Tregs may represent a new and promising Treg family that can be targeted to prevent allograft rejection in the clinic. In this review, we summarize the progress in the field during the past 7&#x02013;10 years and discuss CD8<sup>+</sup> Treg phenotypes, mechanisms of action, and their potential clinical applications; particularly in composite tissue transplants in burn and trauma patients.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>Tolerance</kwd><kwd>transplantation</kwd><kwd>CD8<sup>+</sup> regulatory T cell</kwd><kwd>immune regulation</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Organ transplantation is the preferred treatment of choice for patients with end-stage organ failure. However, the mortality and mobility associated with broad immunosuppression in transplant patients remains a significant barrier to the actual therapeutic potential of organ transplantation. The recent emergence of composite tissue transplantation, which is the treatment of choice for patients suffering from severe burns and trauma, presents new challenges and opportunities for long-term transplant survival without drug-associated toxicities. Induction of immune tolerance is essential for avoiding pathogenic immune responses to self-antigens and alloantigens. Tolerance is also an ideal method of weaning patients off immunosuppressive drugs. It has been well-established that regulatory T cells (Tregs) are critical for maintaining immune tolerance by suppressing both autoimmunity and alloimmunity. There are multiple cell types in the immune system that exhibit immunosuppressive properties. In addition to the much publicized CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Tregs, CD8<sup>+</sup> Tregs have emerged as another key player in immune regulation. Early studies showed that CD8<sup>+</sup> T cells could suppress immune responses, thereby functioning as suppressor cells,[<xref ref-type="bibr" rid="CR12">12</xref>] and tremendous progress has occurred regarding their suppression of alloimmunity and mechanisms of action. For example, Liu <italic>et al.</italic>, demonstrated that CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T cells inhibited T helper alloreactivity in an major histocompatibility complex (MHC) class I-restricted manner.[<xref ref-type="bibr" rid="CR3">3</xref>] These CD8<sup>+</sup> Tregs also induced xenoreactive CD4<sup>+</sup> T-cell anergy. [<xref ref-type="bibr" rid="CR4">4</xref>] Human CD8<sup>+</sup> Tregs inhibited graft-versus-host disease (GVHD) in humanized mice.[<xref ref-type="bibr" rid="CR5">5</xref>] Additionally, either donor-specific or induced CD8<sup>+</sup>FoxP3<sup>+</sup> Tregs facilitated skin allograft survival in certain models.[<xref ref-type="bibr" rid="CR6">6</xref>] Moreover, antigen-induced CD8<sup>+</sup>CD103<sup>+</sup> Tregs have been shown to suppress alloreactive effector T cell function.[<xref ref-type="bibr" rid="CR7">7</xref>] More importantly, several recent studies have shown that CD8<sup>+</sup>CD122<sup>+</sup> T cells are also potent Tregs that inhibit both alloimmunity and autoimmunity.[<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR19">19</xref>] In particular, we have recently found that in an islet transplant model, naturally occurring CD8<sup>+</sup>CD122<sup>+</sup> Tregs in the periphery more potently suppressed allograft rejection than their CD4<sup>+</sup>CD25<sup>+</sup> counterparts. [<xref ref-type="bibr" rid="CR20">20</xref>] Therefore, CD8<sup>+</sup> Tregs may represent a new and promising Treg family that can be targeted to treat autoimmune diseases and allograft rejection in the clinic. Here, we review the most recent progress in the field and discuss potential clinical applications for the induction of tolerance to composite tissue transplants.<table-wrap id="Tab1"><table frame="hsides" rules="groups"><thead><tr><th colspan="2">Access this article online</th></tr></thead><tbody><tr><td rowspan="2">
<bold>Quick Response Code:</bold>
<inline-graphic xlink:href="41038_2014_20010018_Figa.gif" id="d30e390"/>
</td><td>
<bold>Website:</bold>
<ext-link ext-link-type="uri" xlink:href="http://www.burnstrauma.com">www.burnstrauma.com</ext-link>
</td></tr><tr><td>
<bold>DOI:</bold> 10.4103/2321-3868.126086</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec2"><title>CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs</title><p>Previous studies have demonstrated that CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T cells are immunosuppressive.[<xref ref-type="bibr" rid="CR18">18</xref>] Liu <italic>et al.</italic>, originally reported the specific suppression of T helper alloreactivity by MHC class-I-restricted CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T cells,[<xref ref-type="bibr" rid="CR3">3</xref>] which were generated by multiple rounds of <italic>in vitro</italic> allostimulation of peripheral blood mononucleocytes. These MHC class-I-restricted CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T cells induced xenoreactive human CD4<sup>+</sup> T-cell anergy upon specific recognition of MHC class-I antigens.[<xref ref-type="bibr" rid="CR4">4</xref>] Adoptive transfer of CD8<sup>+</sup>CD28<sup>&#x02212;</sup> cells resulted in profound inhibition of corneal xenograft rejection.[<xref ref-type="bibr" rid="CR21">21</xref>] Qa-1-restricted CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T cells regulated the reactivation of both T cells and natural killer T (NKT) cells.[<xref ref-type="bibr" rid="CR22">22</xref>] Human xenospecific CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs inhibited T helper cell responses to porcine aortic endothelial cells by suppressing necrosis factor (NF)-kappa B activity in porcine antigen-presenting cells (APCs).[<xref ref-type="bibr" rid="CR23">23</xref>] Allospecific and induced CD8<sup>+</sup>CD28<sup>&#x02212;</sup> FoxP3<sup>+</sup> Tregs induced immunoglobulin-like transcript (ILT)3<sup>+</sup>/ILT4<sup>+</sup> tolerogenic endothelial cells or APCs, down-regulated the expression of costimulatory (CD80/CD86) and adhesion (CD54/CD58) molecules, thereby suppressing alloimmune responses.[<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR26">26</xref>] Although induced CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs expressed FoxP3,[<xref ref-type="bibr" rid="CR24">24</xref>] natural CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs were FoxP3-negative.[<xref ref-type="bibr" rid="CR27">27</xref>] The induced, but not natural, CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs expressed glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) and cytotoxic T-cell antigen 4 (CTLA4), whereas both Tregs expressed CD62L[<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref>] [<xref rid="Fig2" ref-type="fig">Figure 2</xref>]. Moreover, graft function was maintained with minimal or no immunosuppression in patients that had circulatory CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs.[<xref ref-type="bibr" rid="CR29">29</xref>] The expansion of CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs was associated with the reduced occurrence of acute or chronic rejection.[<xref ref-type="bibr" rid="CR30">30</xref>] The adoptive transfer of CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs from tolerized liver transplant recipients alleviated acute allograft rejection in rats.[<xref ref-type="bibr" rid="CR31">31</xref>] Donor-specific T cell vaccination induced CD4<sup>+</sup>CD25<sup>+</sup> or CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs that promoted transplant tolerance in new recipient mice that received a cardiac allograft.[<xref ref-type="bibr" rid="CR32">32</xref>] Taken together, mounting evidence suggests that CD8<sup>+</sup>CD28<sup>&#x02212;</sup> cells are Tregs that can either suppress allograft rejection or promote allograft tolerance. CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs are the primary effectors of transplant tolerance and act on the endothelium and antigen presenting cells (APCs) to induce a tolerogenic phenotype and inhibit CD4<sup>+</sup> T helper cell alloreactivity.</p></sec><sec id="Sec3"><title>CD8<sup>+</sup>CD103<sup>+</sup> Tregs</title><p>It has been shown that a CD8<sup>+</sup> T cell population lacking CD44 but expressing CD103 produced transforming growth factor beta (TGF-&#x003b2;), inhibit CD4<sup>+</sup> proliferation <italic>in vitro</italic>, and attenuate adoptively transferred ileitis <italic>in vivo</italic>, most likely by counteracting the proinflammatory role of the CD44<sup>high</sup> subset of T cells.[<xref ref-type="bibr" rid="CR33">33</xref>] Therefore, these CD8<sup>+</sup> Tregs exhibit a naive T cell phenotype (CD8<sup>+</sup>CD103<sup>+</sup>CD44<sup>low</sup>CD62L<sup>high</sup>), as shown in <xref rid="Fig1" ref-type="fig">Figure 1</xref>. In contrast, allostimulated CD8<sup>+</sup>CD103<sup>+</sup> Tregs displayed limited effector functions, such as cytotoxicity and interferon (IFN)-&#x003b3; production. Instead, CD8<sup>+</sup>CD103<sup>+</sup> Tregs suppressed alloreactive effector T cells.[<xref ref-type="bibr" rid="CR7">7</xref>] Lu <italic>et al.</italic>, demonstrated that CD8<sup>+</sup>CD103<sup>-</sup> T cells differentiated into CD8<sup>+</sup>CD103<sup>+</sup>FoxP3<sup>+</sup> T cells after <italic>in vitro</italic> stimulation with either alloantigens or transforming growth factor (TGF)-&#x003b2; and that the number of CD8<sup>+</sup>CD103<sup>+</sup> Tregs increased in spontaneously tolerant recipients of a liver allograft.[<xref ref-type="bibr" rid="CR34">34</xref>] Rapamycin not only promoted the <italic>in vitro</italic> generation of CD8<sup>+</sup>CD103<sup>+</sup> Tregs after allostimulation, but also enhanced their suppressive capacity.[<xref ref-type="bibr" rid="CR35">35</xref>] However, a study by Feng <italic>et al.</italic>, found that CD103 expression by CD8<sup>+</sup> T cells was required for the destruction of islet allografts because CD8<sup>+</sup>CD103 T cells failed to infiltrate the islet grafts,[<xref ref-type="bibr" rid="CR36">36</xref>] indicating that CD103 may be an effector but not a regulatory molecule. Therefore, further studies are necessary to better define the role of CD103 in alloreactive CD8<sup>+</sup> T cell functions.</p><fig id="Fig1"><label>Figure 1</label><caption><p>CD8<sup>+</sup> regulatory T cell (Treg) phenotypes. Natural CD8<sup>+</sup>CD122<sup>+</sup> Tregs are CD44<sup>high</sup>CD62L<sup>+</sup>CD127<sup>+</sup> and partially PD-1-positive (PD-1<sup>+/&#x02212;</sup>) but are FoxP3-negative. Natural CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs (nTreg) are CD44<sup>low</sup>CD62L<sup>+</sup> but GITR-CTLA4-FoxP3<sup>&#x02212;</sup>; whereas, induced CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs (iTreg) are CD44<sup>high</sup>CD62L<sup>+</sup>, but GITR<sup>+</sup>CTLA4<sup>+</sup>FoxP3<sup>+</sup>. CD8<sup>+</sup>CD103<sup>+</sup> Tregs are CD44<sup>low</sup>CD62L<sup>high</sup>FoxP3<sup>+</sup>. GITR = Glucocorticoid-induced tumor necrosis factor receptor-related protein, CTLA4 = cytotoxic T-cell antigen 4.</p></caption><graphic xlink:href="41038_2014_20010018_Fig1" id="d30e813"/></fig></sec><sec id="Sec4"><title>CD8<sup>+</sup>CD122<sup>+</sup> Tregs</title><p>Recent studies have shown that naturally occurring CD8<sup>+</sup>CD122<sup>+</sup> T cells control T cell homeostasis and play an important role in the suppression of autoimmune diseases.[<xref ref-type="bibr" rid="CR8">8</xref>] The transfer of CD8<sup>+</sup>CD122<sup>+</sup> Tregs significantly improved the clinical symptoms of experimental autoimmune encephalomyelitis (EAE), indicating a role for CD8<sup>+</sup>CD122<sup>+</sup> Tregs in the recovery phase of EAE.[<xref ref-type="bibr" rid="CR37">37</xref>] Brain DCs expressing the B7-H1 molecule recruit CD8<sup>+</sup>CD122<sup>+</sup> Tregs to the inflammatory site, which causes a decrease in the clinical EAE peak values.[<xref ref-type="bibr" rid="CR38">38</xref>] Notably, CD8<sup>+</sup>CD38<sup>+</sup>CD122<sup>+</sup> Tregs inhibited effector CD4<sup>+</sup> T cell proliferation in an antigen-nonspecific manner and reduced the clinical score of murine EAE as well as delayed disease occurrence.[<xref ref-type="bibr" rid="CR39">39</xref>] A recent study showed that CD8<sup>+</sup>CD122<sup>+</sup> T cells also played a regulatory role in EAE models of HLA-DR3 transgenic mice; whereas, CD8<sup>+</sup>CD122 T cells had an opposite role.[<xref ref-type="bibr" rid="CR16">16</xref>] Furthermore, CD8<sup>+</sup>CD122<sup>+</sup> Tregs suppressed other autoimmune diseases in many animal models. The depletion of CD8<sup>+</sup>CD122<sup>+</sup> T cells increased the incidence of autoimmune Graves&#x02019;hyperthyroidism in a mouse model,[<xref ref-type="bibr" rid="CR40">40</xref>] suggesting that CD8<sup>+</sup>CD122<sup>+</sup> T cells play an essential role in the inhibition of autoimmune hyperthyroidism. B6-Yaa mutant mice developed systemic lupus erythematous-like disease in association with a defect in CD8<sup>+</sup>CD122<sup>+</sup> Treg activity, suggesting that the Treg subset may be utilized to treat systemic lupus erythematous-like autoimmune disease.[<xref ref-type="bibr" rid="CR15">15</xref>] Therefore, in multiple experimental animal models, CD8<sup>+</sup>CD122<sup>+</sup> Tregs play an important role in the suppression of various autoimmune diseases.</p><p>Recent studies have also demonstrated that CD8<sup>+</sup>CD122<sup>+</sup> Tregs play a role in suppressing alloimmune responses. We originally reported that CD8<sup>+</sup>CD122<sup>+</sup> Tregs suppressed murine allograft rejection.[<xref ref-type="bibr" rid="CR17">17</xref>] We also found that the PD-1<sup>+</sup> component of these Tregs were more effective than the unfractionated CD8<sup>+</sup>CD122<sup>+</sup> Treg population;[<xref ref-type="bibr" rid="CR17">17</xref>] whereas, antigen-specific CD8<sup>+</sup>CD122<sup>+</sup>PD-1 cells were memory T cells that could respond to a previously encountered antigen quickly and efficiently. Furthermore, we demonstrated that CD8<sup>+</sup>CD122<sup>+</sup> Tregs were more potent in suppressing allograft rejection than their CD4<sup>+</sup>CD25<sup>+</sup> counterparts,[<xref ref-type="bibr" rid="CR20">20</xref>] suggesting that CD8<sup>+</sup>CD122<sup>+</sup> Tregs may be a better target for the treatment of allograft rejection. In summary, CD8<sup>+</sup>CD122<sup>+</sup> Tregs regulate both autoimmunity and alloimmunity and may participate in immune regulation <italic>in vivo</italic> for various diseases.</p><p>CD8<sup>+</sup>CD122<sup>+</sup> Tregs and the classical CD4<sup>+</sup>CD25<sup>+</sup> Tregs both express the interleukin (IL)-2 receptor. Specifically, CD122 is the &#x003b2; subunit of the IL-2 receptor on T cells; whereas, CD25 is the &#x003b1; subunit of the IL-2 receptor.[<xref ref-type="bibr" rid="CR41">41</xref>] To identify more effective Tregs for potential clinical applications, we evaluated the efficacy of naturally arising CD8<sup>+</sup>CD122<sup>+</sup> vs CD4<sup>+</sup>CD25<sup>+</sup> Tregs for suppressive activities. Surprisingly, we found that CD8<sup>+</sup>CD122<sup>+</sup> Tregs were much more efficient in the suppression of allograft rejection and underwent faster homeostatic proliferation than their CD4<sup>+</sup>CD25<sup>+</sup> counterparts.[<xref ref-type="bibr" rid="CR20">20</xref>] In addition, CD8<sup>+</sup>CD122<sup>+</sup> Tregs produced significantly more IL-10 and were more effective in the suppression of <italic>in vitro</italic> T cell proliferation than their CD4<sup>+</sup>CD25<sup>+</sup> counterparts. Importantly, adoptive transfer of CD8<sup>+</sup>CD122<sup>+</sup> Tregs but not CD4<sup>+</sup>CD25<sup>+</sup> Tregs, together with the infusion of recombinant IL-15, significantly delayed allograft rejection in normal wild-type mice. In contrast, the transfer of CD4<sup>+</sup>CD25<sup>+</sup> Tregs with the administration of either recombinant IL-2 or IL-15 did not significantly prolong islet allograft survival.[<xref ref-type="bibr" rid="CR20">20</xref>] We hypothesized that IL-2 administration promoted the expansion of both CD4<sup>+</sup>CD25<sup>+</sup> Tregs and conventional effector T cells, which did not alter the overall immune balance; whereas, the administration of IL-15 enhanced the expansion and function of CD8<sup>+</sup>CD122<sup>+</sup> but not CD4<sup>+</sup>CD25<sup>+</sup> Tregs. Therefore, naturally occurring CD8<sup>+</sup>CD122<sup>+</sup> Tregs appear to be a more promising target for suppressing allograft rejection than their CD4<sup>+</sup>CD25<sup>+</sup> counterparts. Further studies are warranted to improve CD8<sup>+</sup>CD122<sup>+</sup> Treg therapies and provide additional experimental data for clinical trials.</p></sec><sec id="Sec5"><title>Mechanisms of action</title><p>The mechanisms underlying CD8<sup>+</sup> Treg suppression are not fully understood. However, multiple mechanisms are likely to be involved, including the killing or direct lysis of target cells, the induction of CD4<sup>+</sup> T cell anergy, and the secretion of immunosuppressive cytokines and molecules. Different subsets of CD8<sup>+</sup> Tregs may utilize distinct mechanisms. Studies by Cantor&#x02019;s group have demonstrated that perforin-mediated cytotoxicity is required for the suppressive activity of Qa-1-restricted CD8<sup>+</sup> Tregs;[<xref ref-type="bibr" rid="CR42">42</xref>] whereas, others have shown that CD11c<sup>+</sup>CD8<sup>+</sup> Tregs can directly kill activated CD4<sup>+</sup> T cells through the Fas ligand-Fas death pathway[<xref ref-type="bibr" rid="CR43">43</xref>] [<xref rid="Fig2" ref-type="fig">Figure 2</xref>]. CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs induced xenoreactive human CD4<sup>+</sup> T-cell anergy[<xref ref-type="bibr" rid="CR4">4</xref>] and also downregulated expression of the costimulatory molecules CD80/CD86 on APCs,[<xref ref-type="bibr" rid="CR23">23</xref>] which indirectly block T cell priming by APCs. TGF-&#x003b2; expanded CD8<sup>+</sup>CD103<sup>+</sup> Tregs displayed cytotoxicity towards allospecific effector T cells through cell-to-cell contact.[<xref ref-type="bibr" rid="CR7">7</xref>] Zheng <italic>et al.</italic>, demonstrated that alloantigen-specific suppression by human CD8<sup>+</sup> Tregs was partially dependent on IL-10, TGF-&#x003b2;, GITR and CTLA-4 expression.[<xref ref-type="bibr" rid="CR44">44</xref>] CD8<sup>+</sup>CD28<sup>&#x02212;</sup> Tregs induced ILT3<sup>+</sup>/ILT4<sup>+</sup> expression on endothelial cells or APCs and downregulated costimulatory (CD80/CD86) and adhesion (CD54/CD58) molecules, resulting in reduced alloreactivity.[<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR26">26</xref>] The increased ILT3<sup>+</sup>/ILT4<sup>+</sup> expression, in turn, promoted the differentiation of CD8<sup>+</sup>CD28<sup>&#x02212;</sup> FoxP3<sup>+</sup> Tregs,[<xref ref-type="bibr" rid="CR24">24</xref>] reinforcing their suppressive capacity. Moreover, ILT3 directly induced CD4<sup>+</sup> Th cell anergy and suppressed the differentiation of IFN-&#x003b3;-producing effector CD8<sup>+</sup> CTL.[<xref ref-type="bibr" rid="CR45">45</xref>]</p><fig id="Fig2"><label>Figure 2</label><caption><p>Mechanisms underlying CD8<sup>+</sup> Treg suppression. Mechanisms responsible for CD8<sup>+</sup> Treg suppression include immunosuppressive cytokines and the killing of target T cells via the perforin/granzyme B and Fas L/Fas pathways as well as the downregulation of CD80/CD86 but the upregulation of immunoglobulin-like transcript 3/4 (ILT3/4) that, in turn, promotes CD8<sup>+</sup> Treg expansion antigen presenting cell (APC).</p></caption><graphic xlink:href="41038_2014_20010018_Fig2" id="d30e1252"/></fig><p>The mechanisms of action for CD8<sup>+</sup>CD122<sup>+</sup> Treg suppression are also not well-defined. As shown in <xref rid="Fig2" ref-type="fig">Figure 2</xref>, IL-10 produced by CD8<sup>+</sup>CD122<sup>+</sup> Tregs appears to be a primary mechanism responsible for suppression.[<xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR46">46</xref>] Endharti <italic>et al.</italic>, presented the first data showing that CD8<sup>+</sup>CD122<sup>+</sup> Tregs suppressed IFN-&#x003b3; production and the proliferation of CD8<sup>+</sup> T cells by producing IL-10 <italic>in vitro</italic>.[<xref ref-type="bibr" rid="CR9">9</xref>] CD8<sup>+</sup> Tregs also recognized activated T cells via the interaction of the MHC class I-&#x003b1;&#x003b2; TCR and regulated target T cells by producing IL-10.[<xref ref-type="bibr" rid="CR46">46</xref>] We also observed that the suppression of allograft rejection by IL-10-deficient CD8<sup>+</sup>CD122<sup>+</sup> Tregs was largely diminished.[<xref ref-type="bibr" rid="CR17">17</xref>] Activated CD8<sup>+</sup>CD122<sup>+</sup> Tregs from RasGRP1(-/-) mice synthesized IL-10 and inhibited the proliferation of CD8<sup>+</sup>CD122<sup>&#x02212;</sup> T cells.[<xref ref-type="bibr" rid="CR10">10</xref>] However, IL-10 did not account for all mechanisms underlying CD8<sup>+</sup>CD122<sup>+</sup> Treg suppression.[<xref ref-type="bibr" rid="CR17">17</xref>] Other mechanisms, in addition to IL-10 production, may be involved in CD8<sup>+</sup>CD122<sup>+</sup> Treg suppression. In particular, CD8<sup>+</sup>CD122<sup>+</sup> Tregs also released IFN-&#x003b3; and TGF-&#x003b2; that suppressed CD4<sup>+</sup> T cell activation.[<xref ref-type="bibr" rid="CR16">16</xref>] It remains to be determined whether the perforin/granzyme B pathway is also involved in regulating effector T cells by CD8<sup>+</sup>CD122<sup>+</sup> Tregs. Despite these findings, further studies are required to fully identify the mechanisms responsible for the suppression of alloimmunity or autoimmunity.</p></sec><sec id="Sec6" sec-type="conclusion"><title>Conclusion</title><p>Many recent studies have shown that the CD8<sup>+</sup> component of T cells can also serve as Tregs <italic>in vitro</italic> and <italic>in vivo</italic>, although relatively little is known about these cells compared to the conventional CD4<sup>+</sup>CD25<sup>+</sup> Tregs. CD8<sup>+</sup> cells suppress both alloimmune responses and autoimmunity in many animal models. Multiple subsets of CD8<sup>+</sup> Tregs have been identified thus far, including the CD8<sup>+</sup>CD28<sup>&#x02212;</sup>, CD8<sup>+</sup>CD103<sup>+</sup>, CD8<sup>+</sup>FoxP3<sup>+</sup> and CD8<sup>+</sup>CD122<sup>+</sup> populations. The mechanisms of action of these cells are not well understood because of their plasticity and heterogeneity. Further investigation is necessary to fully understand the distinct mechanisms underlying their suppression as well as the mechanism by which CD8<sup>+</sup> Tregs interact with other types of Tregs in the induction and maintenance of immune tolerance. These studies will help lay the groundwork for potential clinical trials. Most importantly, our new studies reveal that CD8<sup>+</sup>CD122<sup>+</sup> Tregs more potently suppress allograft rejection than their CD4<sup>+</sup>CD25<sup>+</sup> counterparts. Therefore, CD8<sup>+</sup> Tregs likely represent a new and promising Treg family that can be targeted to suppress allograft rejection or induce long-term allograft survival or tolerance in the clinic. This will undoubtedly benefit transplant patients, including those with composite tissue transplants because of trauma and burns.</p></sec></body><back><fn-group><fn><p>
<bold>How to cite this article:</bold> Su J, Xie Q, Xu Y, Li XC, Dai Z. Role of CD8<sup>+</sup> regulatory T cells in organ transplantation. Burn Trauma 2014;2:18&#x02013;23.</p><p>
<bold>Source of Support:</bold> Nil, <bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gershon</surname><given-names>RK</given-names></name><name><surname>Kondo</surname><given-names>K</given-names></name></person-group><article-title>Cell interactions in the induction of tolerance: The role of thymic lymphocytes</article-title><source>Immunology</source><year>1970</year><volume>18</volume><fpage>723</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">4911896</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantor</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>FW</given-names></name><name><surname>Boyse</surname><given-names>EA</given-names></name></person-group><article-title>Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: After immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses</article-title><source>J Exp Med</source><year>1976</year><volume>143</volume><fpage>1391</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1084/jem.143.6.1391</pub-id><pub-id pub-id-type="pmid">1083888</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Tugulea</surname><given-names>S</given-names></name><name><surname>Cortesini</surname><given-names>R</given-names></name><name><surname>Suciu-Foca</surname><given-names>N</given-names></name></person-group><article-title>Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T cells</article-title><source>Int Immunol</source><year>1998</year><volume>10</volume><fpage>775</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1093/intimm/10.6.775</pub-id><pub-id pub-id-type="pmid">9678758</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colovai</surname><given-names>AI</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Ciubotariu</surname><given-names>R</given-names></name><name><surname>Lederman</surname><given-names>S</given-names></name><name><surname>Cortesini</surname><given-names>R</given-names></name><name><surname>Suciu-Foca</surname><given-names>N</given-names></name></person-group><article-title>Induction of xenoreactive CD4<sup>+</sup> T-cell anergy by suppressor CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T cells</article-title><source>Transplantation</source><year>2000</year><volume>69</volume><fpage>1304</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1097/00007890-200004150-00016</pub-id><pub-id pub-id-type="pmid">10798745</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Xiang</surname><given-names>Z</given-names></name><name><surname>Lam</surname><given-names>KT</given-names></name><name><surname>Lewis</surname><given-names>DB</given-names></name><etal/></person-group><article-title>Human CD8<sup>+</sup> regulatory T cells inhibit GVHD and preserve general immunity in humanized mice</article-title><source>Sci Transl Med</source><year>2013</year><volume>5</volume><fpage>168</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/1479-5876-11-168</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerret</surname><given-names>NM</given-names></name><name><surname>Houlihan</surname><given-names>JL</given-names></name><name><surname>Kheradmand</surname><given-names>T</given-names></name><name><surname>Pothoven</surname><given-names>KL</given-names></name><name><surname>Zhang</surname><given-names>ZJ</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name></person-group><article-title>Donor-specific CD8<sup>+</sup> Foxp3<sup>+</sup> T cells protect skin allografts and facilitate induction of conventional CD4<sup>+</sup> Foxp3<sup>+</sup> regulatory T cells</article-title><source>Am J Transplant</source><year>2012</year><volume>12</volume><fpage>2335</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1111/j.1600-6143.2012.04120.x</pub-id><pub-id pub-id-type="pmid">22681667</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>SD</given-names></name><name><surname>Uss</surname><given-names>E</given-names></name><name><surname>van Lier</surname><given-names>RA</given-names></name><name><surname>ten Berge</surname><given-names>IJ</given-names></name></person-group><article-title>Alloantigen-induced regulatory CD8<sup>+</sup>CD103<sup>+</sup> T cells</article-title><source>Hum Immunol</source><year>2008</year><volume>69</volume><fpage>737</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.humimm.2008.08.281</pub-id><pub-id pub-id-type="pmid">18822329</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifa&#x02019;i</surname><given-names>M</given-names></name><name><surname>Kawamoto</surname><given-names>Y</given-names></name><name><surname>Nakashima</surname><given-names>I</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name></person-group><article-title>Essential roles of CD8<sup>+</sup>CD122<sup>+</sup>regulatory T cells in the maintenance of T cell homeostasis</article-title><source>J Exp Med</source><year>2004</year><volume>200</volume><fpage>1123</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1084/jem.20040395</pub-id><pub-id pub-id-type="pmid">15520244</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endharti</surname><given-names>AT</given-names></name><name><surname>Rifa</surname><given-names>IM</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Fukuoka</surname><given-names>Y</given-names></name><name><surname>Nakahara</surname><given-names>Y</given-names></name><name><surname>Kawamoto</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cutting edge: CD8<sup>+</sup>CD122<sup>+</sup> regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8<sup>+</sup> T cells</article-title><source>J Immunol</source><year>2005</year><volume>175</volume><fpage>7093</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.175.11.7093</pub-id><pub-id pub-id-type="pmid">16301610</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Priatel</surname><given-names>JJ</given-names></name><name><surname>Chow</surname><given-names>MT</given-names></name><name><surname>Teh</surname><given-names>HS</given-names></name></person-group><article-title>Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>5973</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.9.5973</pub-id><pub-id pub-id-type="pmid">18424717</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Rifa&#x02019;i</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Shiku</surname><given-names>H</given-names></name><name><surname>Isobe</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name></person-group><article-title>Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8<sup>+</sup>CD122<sup>+</sup> regulatory T cells</article-title><source>Immunology</source><year>2008</year><volume>124</volume><fpage>121</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2567.2007.02747.x</pub-id><pub-id pub-id-type="pmid">18205792</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molloy</surname><given-names>MJ</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Usherwood</surname><given-names>EJ</given-names></name></person-group><article-title>Suppressive CD8<sup>+</sup> T cells arise in the absence of CD4 help and compromise control of persistent virus</article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>6218</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1003812</pub-id><pub-id pub-id-type="pmid">21531895</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endharti</surname><given-names>AT</given-names></name><name><surname>Okuno</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Misawa</surname><given-names>N</given-names></name><name><surname>Toyokuni</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><etal/></person-group><article-title>CD8<sup>+</sup>CD122<sup>+</sup> regulatory T cells (Tregs) and CD4<sup>+</sup> Tregs cooperatively prevent and cure CD4<sup>+</sup> cell-induced colitis</article-title><source>J Immunol</source><year>2011</year><volume>186</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000800</pub-id><pub-id pub-id-type="pmid">21098236</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LX</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Pang</surname><given-names>PY</given-names></name><name><surname>Haley</surname><given-names>D</given-names></name><name><surname>Walker</surname><given-names>EB</given-names></name><etal/></person-group><article-title>CD122<sup>+</sup> CD8<sup>+</sup> Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice</article-title><source>Eur J Immunol</source><year>2010</year><volume>40</volume><fpage>1375</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1002/eji.200839210</pub-id><pub-id pub-id-type="pmid">20186876</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Radfar</surname><given-names>S</given-names></name><name><surname>Sproule</surname><given-names>TJ</given-names></name><name><surname>Roopenian</surname><given-names>DC</given-names></name><name><surname>Cantor</surname><given-names>H</given-names></name></person-group><article-title>CD8<sup>+</sup> T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice</article-title><source>Proc Natl Acad Sci U S A</source><year>2011</year><volume>108</volume><fpage>2010</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1073/pnas.1018974108</pub-id><pub-id pub-id-type="pmid">21233417</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangalam</surname><given-names>AK</given-names></name><name><surname>Luckey</surname><given-names>D</given-names></name><name><surname>Giri</surname><given-names>S</given-names></name><name><surname>Smart</surname><given-names>M</given-names></name><name><surname>Pease</surname><given-names>LR</given-names></name><name><surname>Rodriguez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Two discreet subsets of CD8 T cells modulate PLP(91&#x02013;110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice</article-title><source>J Autoimmun</source><year>2012</year><volume>38</volume><fpage>344</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2012.02.004</pub-id><pub-id pub-id-type="pmid">22459490</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Wan</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Moore</surname><given-names>Y</given-names></name><name><surname>Wan</surname><given-names>F</given-names></name><name><surname>Dai</surname><given-names>Z</given-names></name></person-group><article-title>Cutting edge: Programmed death-1 defines CD8<sup>+</sup> CD122<sup>+</sup> T cells as regulatory versus memory T cells</article-title><source>J Immunol</source><year>2010</year><volume>185</volume><fpage>803</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000661</pub-id><pub-id pub-id-type="pmid">20548035</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Guillonneau C, Picarda E, Anegon I. CD8<sup>+</sup> regulatory T cells in solid organ transplantation. Curr Opin Organ Transplant 2010.</mixed-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Konya</surname><given-names>C</given-names></name><name><surname>Goronzy</surname><given-names>JJ</given-names></name><name><surname>Weyand</surname><given-names>CM</given-names></name></person-group><article-title>Inhibitory CD8<sup>+</sup> T cells in autoimmune disease</article-title><source>Hum Immunol</source><year>2008</year><volume>69</volume><fpage>781</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.humimm.2008.08.283</pub-id><pub-id pub-id-type="pmid">18812196</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Xie</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Natural CD8<sup>+</sup>CD122<sup>+</sup> T cells are more potent in suppression of allograft rejection than CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells</article-title><source>Am J Transplant</source><year>2014</year><volume>14</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1111/ajt.12515</pub-id><pub-id pub-id-type="pmid">24219162</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Prolongation of corneal xenotransplant survival by T-cell vaccination-induced T-regulatory cells</article-title><source>Xenotransplantation</source><year>2008</year><volume>15</volume><fpage>164</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1111/j.1399-3089.2008.00471.x</pub-id><pub-id pub-id-type="pmid">18611224</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varthaman</surname><given-names>A</given-names></name><name><surname>Khallou-Laschet</surname><given-names>J</given-names></name><name><surname>Clement</surname><given-names>M</given-names></name><name><surname>Fornasa</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Gaston</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Control of T cell reactivation by regulatory Qa-1-restricted CD8<sup>+</sup> T cells</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><fpage>6585</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903109</pub-id><pub-id pub-id-type="pmid">20488793</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciubotariu</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Colovai</surname><given-names>AI</given-names></name><name><surname>Platt</surname><given-names>JL</given-names></name><name><surname>Cortesini</surname><given-names>R</given-names></name><name><surname>Suciu Foca Cortesini</surname><given-names>N</given-names></name></person-group><article-title>Human xenospecific T suppressor cells inhibit T helper cell proliferation to porcine aortic endothelial cells, and NF-kappaB activity in porcine APC</article-title><source>Hum Immunol</source><year>2001</year><volume>62</volume><fpage>470</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0198-8859(01)00238-5</pub-id><pub-id pub-id-type="pmid">11334670</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manavalan</surname><given-names>JS</given-names></name><name><surname>Kim-Schulze</surname><given-names>S</given-names></name><name><surname>Scotto</surname><given-names>L</given-names></name><name><surname>Naiyer</surname><given-names>AJ</given-names></name><name><surname>Vlad</surname><given-names>G</given-names></name><name><surname>Colombo</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Alloantigen specific CD8<sup>+</sup> CD28<sup>&#x02212;</sup> FOXP3<sup>+</sup> T suppressor cells induce ILT3<sup>+</sup> ILT4<sup>+</sup> tolerogenic endothelial cells, inhibiting alloreactivity</article-title><source>Int Immunol</source><year>2004</year><volume>16</volume><fpage>1055</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxh107</pub-id><pub-id pub-id-type="pmid">15226269</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciubotariu</surname><given-names>R</given-names></name><name><surname>Colovai</surname><given-names>AI</given-names></name><name><surname>Pennesi</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Smith</surname><given-names>D</given-names></name><name><surname>Berlocco</surname><given-names>P</given-names></name><etal/></person-group><article-title>Specific suppression of human CD4<sup>+</sup> Th cell responses to pig MHC antigens by CD8<sup>+</sup>CD28<sup>&#x02212;</sup> regulatory T cells</article-title><source>J Immunol</source><year>1998</year><volume>161</volume><fpage>5193</fpage><lpage>202</lpage><pub-id pub-id-type="pmid">9820490</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Enis</surname><given-names>DR</given-names></name><name><surname>Koh</surname><given-names>KP</given-names></name><name><surname>Shiao</surname><given-names>SL</given-names></name><name><surname>Pober</surname><given-names>JS</given-names></name></person-group><article-title>T lymphocyte-endothelial cell interactions</article-title><source>Annu Rev Immunol</source><year>2004</year><volume>22</volume><fpage>683</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.22.012703.104639</pub-id><pub-id pub-id-type="pmid">15032593</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scotto</surname><given-names>L</given-names></name><name><surname>Naiyer</surname><given-names>AJ</given-names></name><name><surname>Galluzzo</surname><given-names>S</given-names></name><name><surname>Rossi</surname><given-names>P</given-names></name><name><surname>Manavalan</surname><given-names>JS</given-names></name><name><surname>Kim-Schulze</surname><given-names>S</given-names></name><etal/></person-group><article-title>Overlap between molecular markers expressed by naturally occurring CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells and antigen specific CD4<sup>+</sup>CD25<sup>+</sup> and CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T suppressor cells</article-title><source>Hum Immunol</source><year>2004</year><volume>65</volume><fpage>1297</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.humimm.2004.09.004</pub-id><pub-id pub-id-type="pmid">15556680</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Zitzner</surname><given-names>JR</given-names></name><name><surname>Houlihan</surname><given-names>J</given-names></name><name><surname>Herrera</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><etal/></person-group><article-title>Common gamma chain cytokines promote rapid <italic>in vitro</italic> expansion of allo-specific human CD8<sup>+</sup> suppressor T cells</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><fpage>e28948</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0028948</pub-id><pub-id pub-id-type="pmid">22194954</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sindhi</surname><given-names>R</given-names></name><name><surname>Manavalan</surname><given-names>JS</given-names></name><name><surname>Magill</surname><given-names>A</given-names></name><name><surname>Suciu-Foca</surname><given-names>N</given-names></name><name><surname>Zeevi</surname><given-names>A</given-names></name></person-group><article-title>Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8<sup>+</sup>CD28<sup>&#x02212;</sup> T-suppressor cells</article-title><source>Hum Immunol</source><year>2005</year><volume>66</volume><fpage>252</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.humimm.2004.05.017</pub-id><pub-id pub-id-type="pmid">15784463</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>YX</given-names></name><name><surname>Yan</surname><given-names>LN</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Wen</surname><given-names>TF</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A significant expansion of CD8<sup>+</sup> CD28<sup>&#x02212;</sup> T-suppressor cells in adult-to-adult living donor liver transplant recipients</article-title><source>Transplant Proc</source><year>2009</year><volume>41</volume><fpage>4229</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2009.09.072</pub-id><pub-id pub-id-type="pmid">20005374</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>You</surname><given-names>P</given-names></name></person-group><article-title>The protective effect of CD8<sup>+</sup> CD28<sup>&#x02212;</sup> T suppressor cells on the acute rejection responses in rat liver transplantation</article-title><source>Transplant Proc</source><year>2007</year><volume>39</volume><fpage>3396</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2007.06.089</pub-id><pub-id pub-id-type="pmid">18089392</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><article-title>Adoptive transfer of transplantation tolerance mediated by CD4<sup>+</sup>CD25<sup>+</sup> and CD8<sup>+</sup>CD28<sup>&#x02212;</sup> regulatory T cells induced by anti-donor-specific T-cell vaccination</article-title><source>Transplant Proc</source><year>2008</year><volume>40</volume><fpage>1612</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.transproceed.2008.02.079</pub-id><pub-id pub-id-type="pmid">18589160</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>J</given-names></name><name><surname>Kurtz</surname><given-names>CC</given-names></name><name><surname>Naganuma</surname><given-names>M</given-names></name><name><surname>Ernst</surname><given-names>PB</given-names></name><name><surname>Cominelli</surname><given-names>F</given-names></name><name><surname>Rivera-Nieves</surname><given-names>J</given-names></name></person-group><article-title>A CD8<sup>+</sup>/CD103 high T cell subset regulates TNF-mediated chronic murine ileitis</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>2573</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.4.2573</pub-id><pub-id pub-id-type="pmid">18250468</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Pu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><etal/></person-group><article-title>CD8 (<sup>+</sup>) CD103 (<sup>+</sup>) regulatory T cells in spontaneous tolerance of liver allografts</article-title><source>Int Immunopharmacol</source><year>2009</year><volume>9</volume><fpage>546</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2009.01.021</pub-id><pub-id pub-id-type="pmid">19539566</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uss</surname><given-names>E</given-names></name><name><surname>Yong</surname><given-names>SL</given-names></name><name><surname>Hooibrink</surname><given-names>B</given-names></name><name><surname>van Lier</surname><given-names>RA</given-names></name><name><surname>ten Berge</surname><given-names>IJ</given-names></name></person-group><article-title>Rapamycin enhances the number of alloantigen-induced human CD103<sup>+</sup>CD8<sup>+</sup> regulatory T cells <italic>in vitro</italic></article-title><source>Transplantation</source><year>2007</year><volume>83</volume><fpage>1098</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1097/01.tp.0000259555.29762.f0</pub-id><pub-id pub-id-type="pmid">17452901</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Yuan</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>CM</given-names></name><name><surname>Farber</surname><given-names>DL</given-names></name><name><surname>Hadley</surname><given-names>GA</given-names></name></person-group><article-title>CD103 expression is required for destruction of pancreatic islet allografts by CD8 (<sup>+</sup>) T cells</article-title><source>J Exp Med</source><year>2002</year><volume>196</volume><fpage>877</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1084/jem.20020178</pub-id><pub-id pub-id-type="pmid">12370250</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Ishida</surname><given-names>Y</given-names></name><name><surname>Rifa&#x02019;i</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Isobe</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name></person-group><article-title>Essential role of CD8<sup>+</sup>CD122<sup>+</sup> regulatory T cells in the recovery from experimental autoimmune encephalomyelitis</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><fpage>825</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.180.2.825</pub-id><pub-id pub-id-type="pmid">18178821</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zozulya</surname><given-names>AL</given-names></name><name><surname>Ortler</surname><given-names>S</given-names></name><name><surname>Fabry</surname><given-names>Z</given-names></name><name><surname>Sandor</surname><given-names>M</given-names></name><name><surname>Wiendl</surname><given-names>H</given-names></name></person-group><article-title>The level of B7 homologue 1 expression on brain DC is decisive for CD8 Treg cell recruitment into the CNS during EAE</article-title><source>Eur J Immunol</source><year>2009</year><volume>39</volume><fpage>1536</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1002/eji.200839165</pub-id><pub-id pub-id-type="pmid">19424967</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahri</surname><given-names>R</given-names></name><name><surname>Bollinger</surname><given-names>A</given-names></name><name><surname>Bollinger</surname><given-names>T</given-names></name><name><surname>Orinska</surname><given-names>Z</given-names></name><name><surname>Bulfone-Paus</surname><given-names>S</given-names></name></person-group><article-title>Ectonucleotidase CD38 demarcates regulatory, memorylike CD8<sup>+</sup> T cells with IFN-gamma-mediated suppressor activities</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e45234</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0045234</pub-id><pub-id pub-id-type="pmid">23028866</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>O</given-names></name><name><surname>Abiru</surname><given-names>N</given-names></name><name><surname>Nakahara</surname><given-names>M</given-names></name><name><surname>Nagayama</surname><given-names>Y</given-names></name></person-group><article-title>CD8<sup>+</sup>CD122<sup>+</sup> T cells, a newly identified regulatory T subset, negatively regulate Graves&#x02019;hyperthyroidism in a murine model</article-title><source>Endocrinology</source><year>2007</year><volume>148</volume><fpage>6040</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1210/en.2007-0300</pub-id><pub-id pub-id-type="pmid">17823258</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Sakaguchi</surname><given-names>N</given-names></name><name><surname>Asano</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Toda</surname><given-names>M</given-names></name></person-group><article-title>Immunological self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25)-breakdown of a single mechanism of self-tolerance causes various autoimmune diseases</article-title><source>J Immunol</source><year>1995</year><volume>155</volume><fpage>1151</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">7636184</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Cantor</surname><given-names>H</given-names></name></person-group><article-title>Generation and regulation of CD8<sup>(+)</sup> regulatory T cells</article-title><source>Cell Mol Immunol</source><year>2008</year><volume>5</volume><fpage>401</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/cmi.2008.50</pub-id><pub-id pub-id-type="pmid">19118505</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><article-title>CD11c (high) CD8<sup>+</sup> regulatory T cell feedback inhibits CD4 T cell immune response via Fas ligand-Fas pathway</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><fpage>6145</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1300060</pub-id><pub-id pub-id-type="pmid">23677464</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>G</given-names></name><name><surname>Chan</surname><given-names>PL</given-names></name><name><surname>Mao</surname><given-names>H</given-names></name><name><surname>Lam</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells</article-title><source>J Immunol</source><year>2009</year><volume>183</volume><fpage>3742</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0901329</pub-id><pub-id pub-id-type="pmid">19684082</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlad</surname><given-names>G</given-names></name><name><surname>Cortesini</surname><given-names>R</given-names></name><name><surname>Suciu-Foca</surname><given-names>N</given-names></name></person-group><article-title>CD8<sup>+</sup> T suppressor cells and the ILT3 master switch</article-title><source>Hum Immunol</source><year>2008</year><volume>69</volume><fpage>681</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.humimm.2008.08.286</pub-id><pub-id pub-id-type="pmid">18817834</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rifa&#x02019;i</surname><given-names>M</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>YH</given-names></name><name><surname>Shiku</surname><given-names>H</given-names></name><name><surname>Isobe</surname><given-names>K</given-names></name><etal/></person-group><article-title>CD8<sup>+</sup>CD122<sup>+</sup> regulatory T cells recognize activated T cells via conventional MHC class I-alphabetaTCR interaction and become IL-10-producing active regulatory cells</article-title><source>Int Immunol</source><year>2008</year><volume>20</volume><fpage>937</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxn052</pub-id><pub-id pub-id-type="pmid">18495626</pub-id></element-citation></ref></ref-list></back></article>